189 related articles for article (PubMed ID: 37462942)
21. Rheb regulates nuclear mTORC1 activity independent of farnesylation.
Zhong Y; Zhou X; Guan KL; Zhang J
Cell Chem Biol; 2022 Jun; 29(6):1037-1045.e4. PubMed ID: 35294906
[TBL] [Abstract][Full Text] [Related]
22. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
Inoki K; Li Y; Xu T; Guan KL
Genes Dev; 2003 Aug; 17(15):1829-34. PubMed ID: 12869586
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into TSC complex assembly and GAP activity on Rheb.
Yang H; Yu Z; Chen X; Li J; Li N; Cheng J; Gao N; Yuan HX; Ye D; Guan KL; Xu Y
Nat Commun; 2021 Jan; 12(1):339. PubMed ID: 33436626
[TBL] [Abstract][Full Text] [Related]
24. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
[TBL] [Abstract][Full Text] [Related]
25. Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion.
Martin TD; Chen XW; Kaplan RE; Saltiel AR; Walker CL; Reiner DJ; Der CJ
Mol Cell; 2014 Jan; 53(2):209-20. PubMed ID: 24389102
[TBL] [Abstract][Full Text] [Related]
26. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
[TBL] [Abstract][Full Text] [Related]
27. VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation.
Mohan N; Shen Y; Dokmanovic M; Endo Y; Hirsch DS; Wu WJ
Oncotarget; 2016 Aug; 7(32):52239-52254. PubMed ID: 27409169
[TBL] [Abstract][Full Text] [Related]
28. Amino acid regulation of TOR complex 1.
Avruch J; Long X; Ortiz-Vega S; Rapley J; Papageorgiou A; Dai N
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E592-602. PubMed ID: 18765678
[TBL] [Abstract][Full Text] [Related]
29. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.
Kwiatkowski DJ
Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311
[TBL] [Abstract][Full Text] [Related]
30. Ursolic acid inhibits leucine-stimulated mTORC1 signaling by suppressing mTOR localization to lysosome.
Ou X; Liu M; Luo H; Dong LQ; Liu F
PLoS One; 2014; 9(4):e95393. PubMed ID: 24740400
[TBL] [Abstract][Full Text] [Related]
31. Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment.
Angarola B; Ferguson SM
Mol Biol Cell; 2019 Oct; 30(22):2750-2760. PubMed ID: 31532697
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1.
Zheng M; Wang YH; Wu XN; Wu SQ; Lu BJ; Dong MQ; Zhang H; Sun P; Lin SC; Guan KL; Han J
Nat Cell Biol; 2011 Mar; 13(3):263-72. PubMed ID: 21336308
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
34. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays.
Shams R; Ito Y; Miyatake H
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445471
[TBL] [Abstract][Full Text] [Related]
36. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.
Yang Q; Inoki K; Kim E; Guan KL
Proc Natl Acad Sci U S A; 2006 May; 103(18):6811-6. PubMed ID: 16627617
[TBL] [Abstract][Full Text] [Related]
37. The late endosome is essential for mTORC1 signaling.
Flinn RJ; Yan Y; Goswami S; Parker PJ; Backer JM
Mol Biol Cell; 2010 Mar; 21(5):833-41. PubMed ID: 20053679
[TBL] [Abstract][Full Text] [Related]
38. The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.
Kang YJ; Lu MK; Guan KL
Cell Death Differ; 2011 Jan; 18(1):133-44. PubMed ID: 20616807
[TBL] [Abstract][Full Text] [Related]
39. Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells.
Li C; Liu X; Liu Y; Zhang E; Medepalli K; Masuda K; Li N; Wikenheiser-Brokamp KA; Osterburg A; Borchers MT; Kopras EJ; Plas DR; Sun J; Franz DN; Capal JK; Mays M; Sun Y; Kwiatkowski DJ; Alayev A; Holz MK; Krueger DA; Siroky BJ; Yu JJ
Mol Cancer Res; 2017 Oct; 15(10):1318-1330. PubMed ID: 28710231
[TBL] [Abstract][Full Text] [Related]
40. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.
Zhang J; Kim J; Alexander A; Cai S; Tripathi DN; Dere R; Tee AR; Tait-Mulder J; Di Nardo A; Han JM; Kwiatkowski E; Dunlop EA; Dodd KM; Folkerth RD; Faust PL; Kastan MB; Sahin M; Walker CL
Nat Cell Biol; 2013 Oct; 15(10):1186-96. PubMed ID: 23955302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]